These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 37109205)

  • 1. Atrial Fibrillation and Diabetes Mellitus: Dangerous Liaisons or Innocent Bystanders?
    Lorenzo-Almorós A; Casado Cerrada J; Álvarez-Sala Walther LA; Méndez Bailón M; Lorenzo González Ó
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights.
    Bohne LJ; Johnson D; Rose RA; Wilton SB; Gillis AM
    Front Physiol; 2019; 10():135. PubMed ID: 30863315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epicardial Adipose Tissue and Cardiac Arrhythmias: Focus on Atrial Fibrillation.
    Conte M; Petraglia L; Cabaro S; Valerio V; Poggio P; Pilato E; Attena E; Russo V; Ferro A; Formisano P; Leosco D; Parisi V
    Front Cardiovasc Med; 2022; 9():932262. PubMed ID: 35845044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies.
    Zhang Q; Liu T; Ng CY; Li G
    Cardiovasc Ther; 2014 Oct; 32(5):233-41. PubMed ID: 25065462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue.
    Packer M
    Cardiovasc Diabetol; 2019 Sep; 18(1):121. PubMed ID: 31551089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redistribution of adipose tissue is associated with left atrial remodeling and dysfunction in patients with atrial fibrillation.
    Chen Q; Chen X; Wang J; Zhong J; Zhang H; Wu B; Zheng Z; Xie X; Zhu J; Tang X; Li S
    Front Cardiovasc Med; 2022; 9():969513. PubMed ID: 36035916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus.
    Fauchier L; Boriani G; de Groot JR; Kreutz R; Rossing P; Camm AJ
    Europace; 2021 Dec; 23(12):1873-1891. PubMed ID: 34411235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complex interplay between diabetes mellitus and atrial fibrillation.
    Yildiz M; Lavie CJ; Morin DP; Oktay AA
    Expert Rev Cardiovasc Ther; 2022 Sep; 20(9):707-717. PubMed ID: 35984314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous hydrogen sulfide reduces atrial remodeling and atrial fibrillation induced by diabetes mellitus via activation of the PI3K/Akt/eNOS pathway.
    Xue X; Ling X; Xi W; Wang P; Sun J; Yang Q; Xiao J
    Mol Med Rep; 2020 Sep; 22(3):1759-1766. PubMed ID: 32705232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products induce senescence of atrial myocytes and increase susceptibility of atrial fibrillation in diabetic mice.
    Zheng DL; Wu QR; Zeng P; Li SM; Cai YJ; Chen SZ; Luo XS; Kuang SJ; Rao F; Lai YY; Zhou MY; Wu FL; Yang H; Deng CY
    Aging Cell; 2022 Dec; 21(12):e13734. PubMed ID: 36278684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies.
    Goudis CA; Korantzopoulos P; Ntalas IV; Kallergis EM; Liu T; Ketikoglou DG
    Int J Cardiol; 2015 Apr; 184():617-622. PubMed ID: 25770841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial remodeling and atrial fibrillation in acquired forms of cardiovascular disease.
    Jansen HJ; Bohne LJ; Gillis AM; Rose RA
    Heart Rhythm O2; 2020 Jun; 1(2):147-159. PubMed ID: 34113869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Atrial Remodeling Mechanisms Associated with Atrial Fibrillation.
    Qiu D; Peng L; Ghista DN; Wong KKL
    Cardiovasc Eng Technol; 2021 Jun; 12(3):361-372. PubMed ID: 33650086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic remodeling of intracellular Ca²⁺ signaling during atrial fibrillation.
    Greiser M; Schotten U
    J Mol Cell Cardiol; 2013 May; 58():134-42. PubMed ID: 23298712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart.
    Otake H; Suzuki H; Honda T; Maruyama Y
    Int Heart J; 2009 Sep; 50(5):627-41. PubMed ID: 19809211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European Observational Multicentre Study).
    Creta A; Providência R; Adragão P; de Asmundis C; Chun J; Chierchia G; Defaye P; Schmidt B; Anselme F; Finlay M; Hunter RJ; Papageorgiou N; Lambiase PD; Schilling RJ; Combes S; Combes N; Albenque JP; Pozzilli P; Boveda S
    Am J Cardiol; 2020 Mar; 125(6):901-906. PubMed ID: 31973808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria.
    Colman MA; Aslanidi OV; Kharche S; Boyett MR; Garratt C; Hancox JC; Zhang H
    J Physiol; 2013 Sep; 591(17):4249-72. PubMed ID: 23732649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation.
    Ramos-Mondragón R; Lozhkin A; Vendrov AE; Runge MS; Isom LL; Madamanchi NR
    Antioxidants (Basel); 2023 Oct; 12(10):. PubMed ID: 37891912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium dysregulation in atrial fibrillation: the role of CaMKII.
    Heijman J; Voigt N; Wehrens XH; Dobrev D
    Front Pharmacol; 2014; 5():30. PubMed ID: 24624086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.
    Gumprecht J; Lip GYH; Sokal A; Średniawa B; Mitręga K; Stokwiszewski J; Wierucki Ł; Rajca A; Rutkowski M; Zdrojewski T; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z
    Cardiovasc Diabetol; 2021 Jun; 20(1):128. PubMed ID: 34167520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.